Recent Updates
Recently added Catalysts
VNRX Positive Sentiment

The epigenetic keys to unlocking the full potential of immunotherapy

Tuesday, February 13, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: The article discusses a white paper focused on the role of epigenetics in cancer therapy and immunotherapy. It emphasizes the importance of identifying markers that can predict treatment responses, which could lead to improved patient outcomes. The insights provided aim to enhance the effectiveness of novel immunotherapies.
Price reaction · baseline $21.2 (2024-02-13T16:36:00.000Z) · hit during market hours · 3 other VNRX headline(s) in the window, move may be shared
day 0 close · peak
-1.9%

Market Sentiment Analysis

POSITIVE FACTORS

  • Highlights the potential of epigenetics in improving immunotherapy outcomes.
  • Addresses the need for predictive markers to enhance patient treatment responses.

Full Press Release Details

Our White Paper is a deep dive into the science of epigenetics, and its potential to reveal deep insights into how our bodies react and respond to medication during cancer therapy and immunotherapies.
With the rise of novel immunotherapies, there is a need for markers that are able to predict treatment response or ineffectiveness, in order to improve patient outcomes.

Related Articles

• Press Releases Data Showing the Prognostic Value of its Nu.Q® Cancer Test
• Poster & Publications Cytokine-induced chromatin accessibility in whole blood neutrophils links to sepsis transcriptional states

Data Showing the Prognostic Value of its Nu.Q® Cancer Test

Cytokine-induced chromatin accessibility in whole blood neutrophils links to sepsis transcriptional states

• Share
• Tweet
• Share on Facebook
• Share

Subscribe for Volition product updates .

Or, click here for Investor Updates and press releases .

" * " indicates required fields

Frequently Asked Questions

What is the focus of the white paper?

The white paper examines the role of epigenetics in cancer therapy and immunotherapy.

Why are predictive markers important?

Predictive markers are crucial for improving patient outcomes by indicating treatment responses.

How can epigenetics impact immunotherapy?

Epigenetics can provide insights into how the body reacts to immunotherapy, potentially enhancing its effectiveness.

ShareAdd on Google
Tags: VNRX Viatris Investor Conferences Healthcare immunotherapy cancer therapy epigenetics predictive markers
Last updated: Feb 13, 2024

Biotech snapshot

Cash runway
$3M liquidity · $2M/mo burn
~1 mo
High dilution risk